The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": Current effective inhibitor targeting a 3C-like protease

Protein and Cell

Volumn 4, Issue 4, 2013, Pages 248-250

  Ren, Zhilin ^a,b   Yan, Liming ^a   Zhang, Ning ^d   Guo, Yu ^b   Yang, Cheng ^b,d   Lou, Zhiyong ^a   Rao, Zihe ^a,b,c,d  

^a NANKAI UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d Tianjin Joint Academy of Biomedicine and Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; METETOIN; PROTEINASE; RUPINTRIVIR; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; BINDING SITE; CATALYSIS; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG TARGETING; HUMAN BETACORONAVIRUS 2C EMC 2012; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SARS CORONAVIRUS; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS REPLICATION;

CORONAVIRUS;

EID: 84876428875     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-013-2841-3     Document Type: Article

References (12)

1. Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J., et al. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J 21, 3213-3224.
2. Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., and Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763-1767.
3. Lau, S. K., Li, K. S., Tsang, A. K., Shek, C. T., Wang, M., et al. (2012). Recent transmission of a novel alphacoronavirus, bat coronavirus HKU10, from Leschenault's Rousettes to Pomona leaf-nosed bats: first evidence of interspecies transmission of coronavirus between bats of different suborders. J Virol 86, 11906-11918.
4. Lee, C. C., Kuo, C. J., Ko, T. P., Hsu, M. F., Tsui, Y. C., et al. (2009). Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and pepti-domimetic compounds. J Biol Chem 284, 7646-7655.
5. Li, S., Zhao, Q., Zhang, Y., Zhang, Y., Bartlam, M., et al. (2010). New nsp8 isoform suggests mechanism for tuning viral RNA synthesis. Protein Cell 1, 198-204.
6. Liang, P. H. (2006). Characterization and inhibition of SARS-coronavirus main protease. Curr Top Med Chem 6, 361-376.
7. Shie, J. J., Fang, J. M., Kuo, T. H., Kuo, C. J., Liang, P. H., et al. (2005). Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha, betaunsaturated esters. Bioorg Med Chem 13, 5240-5252.
8. Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., et al. (2008). Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol 82, 2515-2527.
9. Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., et al. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 3, e324.
10. Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., et al. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 100, 13190-13195.
11. Zhao, Q., Li, S., Xue, F., Zou, Y., Chen, C., et al. (2008). Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1. J Virol 82, 8647-8655.
12. Ziebuhr, J., Snijder, E. J., and Gorbalenya, A. E. (2000). Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 81, 853-879.